Odylia Therapeutics Inc

Analysis

Odylia Therapeutics Inc is a registered charity in United States, based in Atlanta, GA. It received its IRS tax-exemption ruling in March 2018, 8 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Odylia Therapeutics Inc reported income of $571k and spending of $867k, spending 152% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $1.3m to $571k (-55%), an average of -18% a year. The sharpest change came in the year to December 2021, when income rose by 467%. Over the whole period it spent 124% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Odylia Therapeutics Inc sits at the 57th percentile: it is larger than about 57% of them. Against every charity in United States with reported income it ranks in the 72nd percentile, and in the 76th percentile within GA. Charities of a similar size with the same main cause include Upper Ohio Valley Sexual Assault ($571k), New Creation Foundation Inc ($571k) and Center for Counseling Families Inc ($571k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 51% and program service revenue 42% of the total. Compensation of current officers, directors and key employees was $231k (27% of expenses). Other salaries and wages came to $251k. At year end it held assets of $9.7m against liabilities of $41k, net assets of $9.6m. It reported 4 employees.